eprintid: 10187713
rev_number: 6
eprint_status: archive
userid: 699
dir: disk0/10/18/77/13
datestamp: 2024-02-26 09:39:44
lastmod: 2024-02-26 09:39:44
status_changed: 2024-02-26 09:39:44
type: article
metadata_visibility: show
sword_depositor: 699
creators_name: Foot, Holly
creators_name: Beyene, Kebede
creators_name: Horne, Rob
creators_name: Fingleton, James
creators_name: Harrison, Jeff
creators_name: Chan, Amy Hai Yan
title: Evaluating the Feasibility of a Community Pharmacy-Delivered Behaviour Change Intervention to Reduce Reliever Reliance in Asthma
ispublished: pub
divisions: UCL
divisions: B02
divisions: C08
divisions: D10
divisions: G11
keywords: adherence, SABA, SRQ, feasibility, pharmacist, asthma
note: © 2024 Foot et al. This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php
and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work
you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
abstract: PURPOSE: The aim of this study was to evaluate the feasibility of a community pharmacy-delivered intervention to shift patients' beliefs about short-acting beta2 agonists (SABA) in asthma management. The study targeted individual beliefs about SABA and assessed actual SABA use, focusing on reducing SABA use as well as adherence to inhaled corticosteroids (ICS) as a preventive measure. PATIENTS AND METHODS: This non-randomized, before-and-after feasibility study enrolled participants with asthma from four community pharmacies in Auckland, New Zealand. Eligible participants were aged 18 years and above and were prescribed a SABA for their asthma. The intervention included the SABA reliance questionnaire to determine the degree of SABA reliance, verbal discussions with pharmacists personalised according to the degree of SABA reliance identified, and referral to general practitioners as appropriate. RESULTS: Of the 44 patients who consented into the study, 19 were in the control group and 16 in the intervention group. Recruitment and retention were modest, with 10 control and five intervention participants completing the 90-day follow-up. Although not statistically significant, preliminary results indicated reduced SABA reliance and increased ICS adherence in the intervention group, and reduced SABA refill. Feedback showed that 78% of intervention participants found the information easy to understand, and 56% expressed intent to consult their general practitioners. Pharmacy staff found the intervention feasible but noted time constraints as a barrier to intervention delivery. CONCLUSION: The study demonstrates that a community pharmacy-delivered intervention is feasible and acceptable to both patients and pharmacists. While preliminary results show a positive effect on reducing SABA reliance and improvement of ICS adherence, the results were not statistically significant due to the small numbers recruited. This suggests a larger randomised trial is indicated. This intervention holds promise for addressing the over-reliance on SABA in asthma management and improving adherence to preventive therapies.
date: 2024-02-07
date_type: published
publisher: DOVE MEDICAL PRESS LTD
official_url: http://dx.doi.org/10.2147/ppa.s445763
oa_status: green
full_text_type: pub
language: eng
primo: open
primo_central: open_green
verified: verified_manual
elements_id: 2247835
doi: 10.2147/PPA.S445763
pii: 445763
lyricists_name: Horne, Robert
lyricists_id: RHORN95
actors_name: Horne, Robert
actors_name: Harris, Jean
actors_id: RHORN95
actors_id: JAHAR68
actors_role: owner
actors_role: impersonator
funding_acknowledgements: [University of Auckland Faculty Research Development Fund]
full_text_status: public
publication: Patient Preference and Adherence
volume: 2024
number: 18
pagerange: 361-371
pages: 11
event_location: New Zealand
issn: 1177-889X
citation:        Foot, Holly;    Beyene, Kebede;    Horne, Rob;    Fingleton, James;    Harrison, Jeff;    Chan, Amy Hai Yan;      (2024)    Evaluating the Feasibility of a Community Pharmacy-Delivered Behaviour Change Intervention to Reduce Reliever Reliance in Asthma.                   Patient Preference and Adherence , 2024  (18)   pp. 361-371.    10.2147/PPA.S445763 <https://doi.org/10.2147/PPA.S445763>.       Green open access   
 
document_url: https://discovery-pp.ucl.ac.uk/id/eprint/10187713/1/PPA-445763-evaluating-the-feasibility-of-a-community-pharmacy-delivered.pdf